SSRI Antidepressant Medications: Adverse Effects and Tolerability
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been routinely identified to cause less severe withdrawal effects than other SSRIs, which has been attributed to its longer half-life 3,30,75 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However many of these drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
From Molecular and anatomical organization of the dorsal raphe nucleus (2019) · cites this paper as Ferguson, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During long-term use of SSRIs, the most troubling adverse effects seem to be gastrointestinal problems, sleep disturbances and sexual dysfunction,49”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“often intolerable side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many patients refusing to take traditional antidepressants due to their side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 497
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder: A Controlled Trial
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., & Lelliott, P. T. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 201
Cited by
Items 401–500 of 670
Drug Repurposing: Exploring Potential Anti-Cancer Strategies by Targeting Cancer Signalling Pathways
Haddad, N. F., Gamaethige, S. M., Wehida, N., & Elbediwy, A. (2024) · Biology · doi:10.3390/biology13060386 · Cited by 10
“TCAs are often associated with adverse side effects such as cardiac block, arrhythmia, and seizures [48].”
BackgroundRethinking the role of trazodone in the different depressive dimensions
Berardelli, I., Amerio, A., Bartoli, F., Cuomo, A., Deste, G., Orsolini, L., Sampogna, G., & Pompili, M. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2363843 · Cited by 10
“Furthermore, questions about the safety and tolerability of selective serotonin reuptake inhibitors (SSRIs) have emerged with their continued use [7].”
BackgroundA qualitative analysis of the psychedelic mushroom come-up and come-down
Brouwer, A., Brown, J. K., Erowid, E., Erowid, F., Thyssen, S., Raison, C. L., & Carhart-Harris, R. L. (2025) · npj Mental Health Research · doi:10.1038/s44184-024-00095-6 · Cited by 19
“For example, aversivefeelingsinthecome-upoverlaptosomeextentwiththeadverseside effectsofserotoninselectivereuptakeinhibitor(SSRI)antidepressants 32,33 ; side effects that may occur before therapeutic effects are noticed.”
Bowers, H. M., Kendrick, T., van Ginneken, N., Glowacka, M., Williams, S. J., Leydon, G., May, C. R., Dowrick, C. F., Moncrieff, J., Johnson, C. F. A., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25537 · Cited by 10
Ülker, N., Yardımcı, A., Tektemur, N. K., Çolakoğlu, N., Özcan, M., Canpolat, S., & Keleştimur, H. (2020) · Reproductive Biology · doi:10.1016/j.repbio.2020.03.009 · Cited by 8
Accinni, T., Panfili, M., Tarsitani, L., Biondi, M., Pasquini, M., & Maraone, A. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/3801235 · Cited by 10
Effect of comedication of bupropion and other antidepressants on body mass index
Ravindran, P. P., Zang, W., Renukunta, S., Mansour, R., & Denduluri, S. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315577057 · Cited by 8
“SSRIs target the negative allosteric regulation of serotonin reuptake pump, increasing serotonin concentration in specific regions which impacts other physiological functions like appetite, sleep and sexual function [Stahl, 1998; Ferguson, 2001; Raymond et al.”
BackgroundSurana, A. R., & Wagh, R. D. (2018) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.14622 · Cited by 9
Pereira, A. C., Guimarães, C. F., Pereira, S. I. V., Crevelin, E. J., Pinto, G. H. T., Morel, L. J. D. F., Bertoni, B. W., França, S. D. C., & Contini, S. H. T. (2019) · Planta Medica International Open · doi:10.1055/a-0787-1665 · Cited by 9
“Although treatment with synthetic antidepressants is available, many patients suffer from side effects such as dry mouth, constipation, dizziness, blurred vision, increased appetite, weight gain, insomnia, and kidney problems [2].”
BackgroundEvaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications
Kingsberg, S. A., McElroy, S. L., & Clayton, A. H. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.12.003 · Cited by 8
Perspectives on Premenstrual Syndrome/Premenstrual Dysphoric Disorder
Bahamondes, L. G., Córdova-Egüez, S., Pons, J. E., & SHULMAN, L. P. (2007) · Disease Management & Health Outcomes · doi:10.2165/00115677-200715050-00001 · Cited by 8
“[100] results have prompted the ACOG Committee to suggest that COCs For example, the original placebo-controlled trials of fluoxetine in should be considered if symptoms are primarily physical, but that patients with depression reported rates of sexual dysfunction of they may not be effective if mood symptoms are pred…”
ResultThe 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile
Boustany, A., Feuerstadt, P., & Tillotson, G. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02972-0 · Cited by 9
“Gastrointestinal (GI) disturbances are among the most common side effects of SSRIs [25], and genetic variations in the 5-HT system can predict these side effects [26].”
BackgroundWu, Y., Zhu, Y., Zheng, S., & Mingxing, D. (2025) · Future Science OA · doi:10.1080/20565623.2025.2463852 · Cited by 9
“…which include weight gain, sexual dysfunction, gastrointestinal issues, and sleep disturbances, can significantly impair quality of life [7]. therefore, exploring novel agents with less or no side effects is necessary for the intervention of depression. increasing studies and evidence…”
The importance of long-term tolerability in achieving recovery
Baldwin, D. S. (2006) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500600552552 · Cited by 8
“Nausea is one of the more commonly reported adverse events in SSRI-treated patients [15,36].”
BackgroundInfluentialIelmini, M., Poloni, N., Caselli, I., Bianchi, L., Diurni, M., Vender, S., & Callegari, C. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4567 · Cited by 7
O’Callaghan, L., Chertavian, E., Johnson, S. J., Ferries, E., & Deligiannidis, K. M. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2327946 · Cited by 11
“SSRIs have also been associated with a range of adverse events that may affect treatment outcomes 57,58 .”
Buard, I., Lopez‐Esquibel, N., Schoeneberger, S., Berliner, J. M., & Kluger, B. M. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000224 · Cited by 8
Neurostimulation therapies in major depressive disorder: A decision‐analytic model
Teng, M., Khoo, A. L., Zhao, Y. J., Abdin, E., Mok, Y. M., Lim, B. P., & Tor, P. C. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13091 · Cited by 8
“The model included adverse events associated with antidepressants (Fava et al., 2006; Ferguson, 2001; McGrath et al., 2006; Rush, Trivedi, Wisniewski, Nierenberg, et al., 2006; Rush, Trivedi, Wisniewski, Stewart, et al., 2006; Trivedi et al., 2006).”
Chow, J., Thompson, A. J., Iqbal, F., Zaidi, W., & Syed, N. I. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.603789 · Cited by 8
“Moreover, while some side effects of sertraline have been established, such as fatigue, anxiety, and sexual dysfunction (Ferguson, 2001; US Food and Drug Administration, 2008), its impact on nonserotonergic systems, such as cholinergic transmission that underlies learning, memory and plasticity remains unknown.”
BackgroundKoirala, B., Rauniar, G. P., & Shakya, D. R. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20150366 · Cited by 7
Allsbrook, M., Fries, B. E., Szafara, K. L., & Regal, R. E. (2016) · PubMed Central · Cited by 7
Lee, H. G., Kwon, Y., & Chun, Y.-J. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01581-x · Cited by 10
“Owing to their high selectivity for serotonin receptors, SSRIs are widely employed as monotherapy and in combination with other treatments (Ferguson 2001).”
Li, J., Lin, C., Liao, K.-R., & Liao, C.-C. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7060934 · Cited by 7
The application of the Fischer indole synthesis in medicinal chemistry
Seen, S. B., Gong, Y. L., & Ashton, M. (2022) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2022.11.001 · Cited by 11
Huijbers, M. J., Wentink, C., Lucassen, P. L., Kramers, C., Akkermans, R., Spijker, J., & Speckens, A. E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290965 · Cited by 7
Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression
Zhao, Y., Wan, J., & Li, Y. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16046 · Cited by 7
Controlled ultrasonic interventions through the human skull
Wilson, M. G., Riis, T. S., & Kubanek, J. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1412921 · Cited by 8
“One in three patients with a neurological or mental disorder does not respond to drugs or other forms of treatment (Ferguson, 2001; Karceski, 2007; Louis et al., 2010; Al-Harbi, 2012; Jaffe et al., 2019).”
BackgroundWhen Is Pharmacotherapy Initiation Beneficial in Patients With Depressive Disorders?
Prescott, D., & White, N. D. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827616686051 · Cited by 8
“Long-term side effects associated with SSRIs can include gastrointestinal disturbances, weight gain, sexual dysfunction, and sleep disturbance.(9) Counsel the patient on the risk of abruptly stopping pharmacologic treatment, because discontinuation without tapering can often lead to undesirable symptoms and suicidal b…”
BackgroundLai, L., Alvarez, G., Dang, L., Vuong, D., Ngo, V., Jo, Y., & Koh, L. (2019) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12320 · Cited by 6
Hieronymus, F., & Østergaard, S. D. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.05.015 · Cited by 6
Nuthalapati, P., Kigga, M., Rose, J. J., Potla, K. M., Vankayalapati, S., Chinnam, S., Adimoole, S. P., & Pillai, R. R. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131859 · Cited by 6
Antidepressants for menopausal symptoms
Karanth, L., Chuni, N., & Nair, N. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013417 · Cited by 6
RetractedThe Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia
Du, X., & Hill, R. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0813-9 · Cited by 6
“…such as antidepressants, which have been shown to possess the ability to increase BDNF, have delayed action and low efficacy and also come with unwanted psychotropic effects and adverse reactions (Ferguson 2001; Kozisek et al. 2008; Malberg and Blendy 2005; Stassen et al. 1997; Uher et al. 2009).”
Hicks, A. J., Clay, F. J., Hopwood, M., James, A. C., Perry, L. A., Jayaram, M., Batty, R., & Ponsford, J. L. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2020.7277 · Cited by 5
Fornaro, M., & Martino, M. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-39 · Cited by 4
“As a consequence, such high doses of drugs (often beyond in-label ranges), can be associated with unpleasant side effects, including nausea as one the most frequent occurrences [12].”
BackgroundNinety-six hours ordeal of priapism induced by paroxetine—A case report and literature review
Bhat, I., Shannon, K. D., Ara, A., & Coe, I. A. (2015) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217415610312 · Cited by 5
A Comparison of Sexual Side Effects of Antidepressants With and Without Naltrexone
Thapa, M., Petrakis, I. L., & Ralevski, E. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1326650 · Cited by 6
“This leaves a possibility of underreporting the symptoms, as studies have shown that if sexual symptoms are not directly evaluated, patients are unlikely to report them (Ferguson, 2001).”
BackgroundAntidepressant and antianxiety properties of saffron
Mohajeri, S. A., Sepahi, S., & Ghorani‐Azam, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818638-1.00028-9 · Cited by 11
Zandifar, A., Badrfam, R., Shamabadi, A., Jalilevand, S., Pourmirbabaei, S., Torkamand, F., Sahebolzamani, E., & Akhondzadeh, S. (2021) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v16i1.5379 · Cited by 6
“Constipation via tricyclic antidepressant use, nausea, appetite change, and diarrhea by selective serotonin receptor inhibitors are the most common side effects (32).”
BackgroundEscitalopram-induced epistaxis: A case report
Aljhani, S. (2021) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2021.06.004 · Cited by 5
“These complications might be mediated by different subtypes of serotonin receptors and increased serotonin levels.(1) SSRIs are also known to affect platelet activation and aggregation, thereby increasing the bleeding time.”
BackgroundInfluentialA New Paradigm Shift in Antidepressant Therapy: From Dual-action to Multitarget-directed Ligands
Rodríguez-Lavado, J., Alarcón‐Espósito, J., Mallea, M., & Lorente, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220317121551 · Cited by 5
The Effect of Irisin on Thyroid Hormone Levels in Chronic Paroxetine-Treated Rats
Ercan, Z., Dogru, M. S., Ülker, N., Yardımcı, A., & Canpolat, S. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03204-8 · Cited by 6
“Selective serotonin reuptake inhibitors (SSRIs) are the most widely prescribed antidepressants worldwide [6].”
BackgroundDiksha, Singh, L., & Bhatia, D. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01302-7 · Cited by 6
“…drugs come with certain typical adverse effects namely QT prolongation, serotonin syndrome, insomnia, rashes, hyponatremia in the initial weeks and sexual dysfunction, weight gain, etc. later on (Nachimuthu et al. 2012; Spore 1995; Prabhakar and Sablaban 2019; Ferguson 2001; Goethe et al. 2007).”
Chin Tremors Associated with Paroxetine in a Patient with Pancreatic Adenocarcinoma
John, P., McConnell, K., & Saif, M. W. (2013) · PubMed · doi:10.6092/1590-8577/1908 · Cited by 5
“Therefore the side effect profile of SSRIs reported in clinical trials is not necessarily reflective of what patient’s experience [10].”
BackgroundThe pharmacological management of depression – Update 2017
Osuch, E., & Marais, A. (2017) · South African Family Practice · doi:10.4102/safp.v59i1.4625 · Cited by 7
“99 (30) Initial dose of 25-50 mg Increase in 25 mg increments max 300 mg/day Pronounced anticholinergic effects and most sedating TCA”
InfluentialDrug utilization patterns of antidepressants in Federal Neuro-Psychiatric Hospital Lagos, Nigeria
Kehinde, O., Anyika, E. N., & Abah, I. O. (2017) · Journal of Hospital Administration · doi:10.5430/jha.v6n5p12 · Cited by 9
Biomarkers of Obsessive-Compulsive Disorder Subtypes: A Literature Review
Proshina, E. A., Gaidareva, A., Beskhizhko, M., Kazaryan, G., Bainbridge, E., & Khayrullina, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178578 · Cited by 8
“According to research, about 50% of OCD patients do not see the expected results from antidepressant therapy [26].”
Mahmoudi, R., Sartang, M. M., Servatyari, K., & Rafieipour, N. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2602153 · Cited by 9
“Conventional pharmacological agents are frequently associated with adverse effects such as anticholinergic reactions, nausea, constipation, weight fluctuations, and potential drug interactions [18,19].”
Citrullus colocynthis fruit extract as an anti-depressant in mice
Nafisi, S., Rezazadeh, L., Hosseini, E., Shamsi, M., Mousavi, A. B., & Bahrami, A. M. (2016) · Journal of Basic Research in Medical Sciences · doi:10.18869/acadpub.jbrms.3.4.49 · Cited by 4
“Furthermore, these drugs commonly cause gastrointestinal adverse effects, sleeplessness, headache, nervousness and sexual disorders (5, 6).”
BackgroundOng, J. S., Liu, Y.-W., Liong, M., Choi, S. B., Tsai, Y.-C., & Low, W. Y. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.052 · Cited by 4
Abubakar, A. R., Sani, I. H., Malami, S. A., Yaro, A. H., Jahan, I., Adnan, N., Kumar, S., Islam, S., Dutta, S., Charan, J., et al. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i3.52790 · Cited by 8
Zhang, H., Wu, Z., Cao, L., Su, Y., Wang, F., Hong, W., Cai, Y., Peng, D., & Fang, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.011 · Cited by 4
Maratha, S. R., Sharma, V., & Walia, V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00858-6 · Cited by 6
Masuka, J. T., Mchunu, N. N., Mkhize, Z., Thandar, Y., & Mosam, A. (2021) · Australasian Journal of Dermatology · doi:10.1111/ajd.13780 · Cited by 5
“Selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacological treatment for major depressive disorders (MDD) owing to their better safety and tolerability profile compared to other antidepressants.(1,2) SSRIs are also indicated for bulimia nervosa, anxiety, panic and obsessive-compulsi…”
BackgroundGarvik, O. S., Jølving, L. R., Lund, K., Friedman, S., & Nørgård, B. M. (2024) · Andrology · doi:10.1111/andr.13646 · Cited by 4
Quigley, B. L., Can, A., Dutton, M., Gallay, C. C., Forsyth, G., Jones, M., Randall, F., Wilson, P. A., Lagopoulos, J., & Hermens, D. F. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.01.003 · Cited by 4
O'Brien, D., Healy, A. M., Harkin, A., & Cadogan, C. A. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70082 · Cited by 5
Muzaffer, U., Gull, B., Ahmed, Z., & Ahmad, M. (2025) · Current Neuropharmacology · doi:10.2174/1570159x23666250523112027 · Cited by 6
From social to socio-material pathologies: on Latour, subjectivity and materiality
Birk, R. H. (2016) · Distinktion Journal of Social Theory · doi:10.1080/1600910x.2016.1182040 · Cited by 9
Jaggar, M., Banerjee, T., Weisstaub, N., Gingrich, J. A., & Vaidya, V. A. (2019) · Neuronal Signaling · doi:10.1042/ns20180205 · Cited by 5
Kamran, S., Khan, Z., Saqlain, M., Nazar, Z., Khan, M., Ali, Z., Rashid, H., Shah, K. U., Karataş, Y., & Rahman, N. U. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2022.2021073 · Cited by 6
“However, the longterm use of SSRIs can lead to significant side effects, including sleep disturbances, weight gain, and sexual dysfunction [38].”
BackgroundWhole-Genome Association Analysis of Treatment Response from Obsessive-Compulsive Disorder
Ritter, M. L., & Qin, H. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1071-3_5 · Cited by 4
Singh, A., Arun, P., Singh, G., Kaur, D., & Kaur, S. (2022) · Clinical EEG and Neuroscience · doi:10.1177/15500594221142396 · Cited by 4
“28 In this study no signi fi cant association was found between sociodemographic variables and response.”
BackgroundBrooks, S., Zuiker, R. G. J. A., Bleys, C., Ziagkos, D., Moyer, J., Nueten, L. V., Bonaventure, P., Drevets, W. C., van Gerven, J., Salvadore, G., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231167989 · Cited by 7
“…project widely throughout the central nervous system (CNS), the panicolytic effects of currently available drugs may result from more efficient cortico-limbic modulation of fear and anxiety-related neurocircuitry due to structural adaptations over time (Felten and Sladek, 1983; Ferguson, 2001).”
BackgroundSchoenrock, S. A., & Tarantino, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00009-7 · Cited by 9
Tang, K., Wang, B., Yang, L., Li, L., Zhou, Y., & Yang, C.-H. (2014) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2333 · Cited by 4
Frase, L., Doerr, J. P., Feige, B., Rechenbach, M., Fiebich, B. L., Riemann, D. W., Nissen, C., & Voderholzer, U. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.3.253 · Cited by 4
Ouanounou, A., & Ng, K. (2019) · PubMed · Cited by 7
Newale, S., & Bachani, D. S. (2016) · PubMed · Cited by 6
Centella asiatica increases B-cell lymphoma 2 expression in rat prefrontal cortex
Kuswati, K., Prakosa, D., Wasita, B., & Wiyono, N. (2016) · Universa Medicina · doi:10.18051/univmed.2015.v34.10-16 · Cited by 4
“One class of antidepressant drug, the selective serotonin reuptake inhibitors (SSRIs), have side effects such as nausea, sleep disturbances, sexual dysfunction, changes in appetite, headache and dry mouth.((6)) Therefore, it is necessary to find an alternative drug to inhibit apoptosis, one of which can be found in th…”
BackgroundCulbertson, V. L., Rahman, S. E., Bosen, G. C., Caylor, M. L., & Xu, D. Q. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2215 · Cited by 5
“A clinical review of SSRI adverse effects and tolerability lists 37 potential serotonin-mediated ADEs, 6 and a meta-analysis comprising 84 well-controlled studies reports 18 ADES associated with TCAs and SRIs, suggesting that ADEs are common.”
BackgroundPadmapriya, C., Pushkarapriya, S., Shanmugapriya, N., Sushmitha, K. P., Karthik, S., & Rajanandh, M. G. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.059 · Cited by 9
Monoamine transporters as continuing targets for drug discovery in depression
Klint, T., & Weikop, P. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.014 · Cited by 4
Hypermobility and autonomic hyperactivity : relevance for the expression of psychiatric symptoms
Eccles, J. (2016) · Cited by 5
When is it appropriate to treat children with social anxiety, pharmacologically?
Snir, A., Moskow, D. M., & Hofmann, S. G. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1948015 · Cited by 3
“To date, aside from SSRIs and SNRIs, data are insufficient to categorically recommend other classes of anti-anxiety drugs in children over another.”
BackgroundInfluentialA large-scale observational comparison of antidepressants and their effects
Heinz, M. V., Yom‐Tov, E., Mackin, D. M., Matsumura, R., & Jacobson, N. C. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.001 · Cited by 8
Salcedo, P. A., Volpe, D. A., Chaturbedi, A., Shah, A., Krishna, A., Hyland, P. L., Vegesna, G., Hsiao, C., Palma, R. M. D., Fein, M., et al. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70219 · Cited by 4
“44 A systematic review of patients with MDD demonstrated that increased ADRs directly correlated with reduced medication adherence, with approximately 50% of patients failing to follow prescribed regimens.”
Modern Cancer Research on Chinese Medicine: Acupuncture
Zhang, R.-X., & Lao, L. (2009) · Springer eBooks · doi:10.1007/978-90-481-3555-4_10 · Cited by 3
Yang, J., Bao, C., & Gu, J. (2024) · International Wound Journal · doi:10.1111/iwj.14656 · Cited by 3
“21 Although the aforementioned adverse effects are cause for concern, the treatment group exhibited greater levels of overall treatment satisfaction and perceived quality of life enhancement.”
BackgroundRetractedGamne, R., Misar, S. D., & Rai, M. (2024) · F1000Research · doi:10.12688/f1000research.139473.2 · Cited by 4
Hansali, S., Pio‐Lopez, L., LaPalme, J. V., & Levin, M. G. (2025) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2025.3575233 · Cited by 3
“Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs prescribed for cases of depression and anxiety [142], [143], [144], [145].”
Bali, V., Johnson, M. L., Chen, H., Fleming, M. L., Holmes, H. M., & Aparasu, R. R. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015618978 · Cited by 3
“Additionally, anticholinergic, sedative, or hypotensive side effects are not common with SNRIs.(20) Some studies also suggest that antidepressants yield little cognitive improvement in non-demented depressed older adults, and depression-related cognitive impairment may persist even after adequate treatment with antide…”
BackgroundInfluentialBupropion extended-release induced spontaneous orgasms
Örüm, M. H., Eğilmez, O. B., & Kalenderoğlu, A. (2018) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2018310112 · Cited by 3
“Sexual side effects of antidepressant drugs are commonly observed (1).”
BackgroundLi, C., Chen, L., Huo, N., Mishuk, A. U., Hansen, R. A., Harris, I., Kiptanui, Z., Wang, Z., & Qian, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232226 · Cited by 3
“However, possible reasons for higher discontinuation rate and lower persistent use rates for antidepressant treatments have been studied extensively and attributed to patients’ poor drug adherence [47], side effects [48, 49], concerns with medication tolerability [50], and increased healthcare costs [6, 7, 51].”
BackgroundIdentification of the antidepressive properties of C1, a specific inhibitor of Skp2, in mice
Li, F., Huang, C., Lu, X., Xiang, H., Wang, D., Chen, Z., Chen, J., He, H., & Yuan, X. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000604 · Cited by 3
“Furthermore, the antidepressants in the clinic also display a diversity of adverse effects, such as dizziness, erectile dysfunction, and sleep disturbance (Ferguson, 2001; Crawford et al., 2014), which to a large extent affect the use of these drugs in depression treatment.”
BackgroundHwang, S., Lee, D. Y., Cho, J., Chung, J., Jang, I., Yu, K., & Lee, S. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s309763 · Cited by 3
“Based on the assessments of safety and tolerability, the most commonly observed AEs were consistent with the previously reported AEs of SSRIs.13 The risk of QT prolongation with SSRIs has recently become an important consideration for the selection of SSRIs.26–29 Moreover, in the case of DA-8031, the preclinical and f…”
ResultTasorian, B., Tabatabaei, M., & Shayganfard, M. (2022) · Shiraz E-Medical Journal · doi:10.5812/semj-117966 · Cited by 3
“Some other studies showed that psychiatric medications may be associated with potentially adverse side effects or even lead to exacerbation of RA symptoms (1, 9, 10).”
BackgroundCha, D. S., Kleine, N., Teopiz, K. M., Vincenzo, J. D. D., Ho, R., Galibert, S. L., Samra, A., Zilm, S. P. M., Cha, R. H., d’Andrea, G., et al. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2298340 · Cited by 4
Alsugeir, D. M., John, M., Tillyer, E., Wei, L., & Brauer, R. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2409316 · Cited by 5
“Dizziness is common with the use of SSRIs, particularly upon initiation of drug therapy [35].”
Behandeling van suïcidaal gedrag in een psychiatrische kliniek
de Winter, R. F. P., & Beurs, D. P. D. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0972-6_17 · Cited by 3
The pharmacological management of depression
Osuch, E., Makiwane, M., Motswaledi, C., & Taylor-Memmory, R. (2023) · South African General Practitioner · doi:10.36303/sagp.0171 · Cited by 4
Can (immune and other) gene expression help us to treat depression?
Mariani, N. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100323 · Cited by 3
“…medications is currently based on clinical characteristics (e.g., possible side-effect and previous history of response) or non-clinical factors (e.g., patient or provider preference, cost and availability on insurer's approved drug list) (Gelenberg et al., 2010), rather than biological features.”
Kaufman, K. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.006 · Cited by 3
Music Therapy as a Treatment for Patients with Post-Traumatic Stress Disorder
Miller, C. (2015) · Journal of Psychotherapy & Psychological Disorders · doi:10.4172/2471-4372.1000103 · Cited by 3
“In one study, after examining patients who were on long term SSRI treatments, up to 75% of individuals were found to have acquired adverse effects from the drugs, including sexual dysfunction [6].”
BackgroundInfluentialRisk Factors for Overweight in Children with Autism Spectrum Disorder
Grondhuis, S. N., & Aman, M. G. (2016) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-016-9522-0 · Cited by 3
Thormann, J., Chittka, T., Minkwitz, J., Kluge, M., & Himmerich, H. (2013) · Cited by 3
Kuśmider, M., Faron‐Górecka, A., Pabian, P., Solich, J., Szlachta, M., Kolasa, M., Żurawek, D., Wójcikowski, J., Daniel, W. A., & Dziedzicka‐Wasylewska, M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.11.016 · Cited by 3
“…regarding the required extended duration of use, impatience with the delayed onset of action, side effects, that emerge on ADs initiation, such as anxiety and insomnia, or after extended use, such as sexual dysfunction and weight gain, or overall perception of clinical improvement (Ferguson, 2001).”
Ouellet, M., Beaulieu‐Bonneau, S., & Morin, C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813014-8.00010-x · Cited by 4
Morshedi, F., Morovvati, H., Sadeghinezhad, J., Taheri, M., & Anbara, H. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Steyn, S. F. (2011) · Boloka Institutional Repository (North-west University) · Cited by 5
Metadata
- Authors
- Ferguson, J. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Ferguson, James M.
- ORCID
- Ferguson, James M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-01
- Volume
- 3
- Issue
- 1
- Pages
- 22-27
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- PMC
- PMC181155
- OpenAlex
- W2024985387
- Cited by
- 669
- References
- 23
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 33 · 2023: 46 · 2022: 63 · 2021: 69 · 2020: 56 · 2019: 64 · 2018: 45 · 2017: 47 · 2016: 36 · 2015: 28 · 2014: 27 · 2013: 24 · 2012: 11
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, antidepressant side effects, sexual dysfunction, weight gain, sleep disorders, depression treatment, primary care management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.